MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Status:
Not yet recruiting
Trial end date:
2030-11-30
Target enrollment:
Participant gender:
Summary
This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion
(α/β TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with
hematological malignancies